Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell Carcinoma.

Hiroshi Masuda,Kosuke Mikami,Kotaro Otsuka,Kyokusin Hou,Takahito Suyama,Kazuhiro Araki,Satoko Kojima,Yukio Naya

Cancer diagnosis & prognosis（2021）

Cited 1|Views7
No score
Abstract
Combination immunotherapy with nivolumab plus ipilimumab was demonstrated to be effective in a hemodialysis patient with mRCC.
More
Translated text
Key words
Fungal pneumonia,hemodialysis,immunotherapy,metastatic renal cell carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined